Insights

In the first of two episodes, Drs Millie Long and Raymond Cross discuss their choices of the best abstracts on inflammatory bowel disease from the Digestive Disease Week conference held in May.

Dr Caldera, from the University of Wisconsin, reviews results of the HERCULES study assessing immunological response to vaccines among patients with inflammatory bowel disease.

Dr Rieder discusses available and upcoming therapies and positioning of medications for Crohn's disease.

Dr Allegretti reviews the results of the phase 3 QUASAR trial of the interleukin-23 inhibitor guselkumab in ulcerative colitis.

Dr Ananthakrishnan, from Massachusetts General Hospital in Boston, reviews data from prospective studies on how diet can increase the risk of developing inflammatory bowel disease.

Dr Kayal, from the Icahn School of Medicine at Mt Sinai, discusses her presentation from Digestive Disease Week on complications of the pouch among patients who have undergone ileal pouch anal anastamosis.

In a special edition of IBD Drive Time, guest host David Rubin, MD, discusses how inflammatory bowel disease can affect sexual function. He is joined by his University of Chicago colleagues Alyse Bedell, PhD, GI psychologist and sex...

In the third episode of IBD Drive Time, host Raymond Cross, MD, discusses research into how diet can alleviate symptoms—or worsen disease—among patients with Crohn's disease with Dr James Lewis, who conducted the DINE-CD study.

Dr Allegretti reviews her presentation at the Advances in Inflammatory Bowel Disease regional meeting on how to position sphingostine 1-phosphate receptor modulators to optimize patient care in IBD.

Dr Moss recaps his presentation on the safety and efficacy of Janus kinase inhibitors in the treatment of inflammatory bowel disease from the AIBD regional meeting.